Literature DB >> 931374

Animal fecal carriership and biotypes of Staphylococcus aureus.

G Dimitracopoulos, H Kalkani-Boussiakou, J Papavassiliou.   

Abstract

Staphylococcus aureus was found in 44% of the rectal swabs from 377 pigs and in 12% of the swabs from 147 cows. Seventy-one percent of the isolates from pigs showed fibrinolytic activity and grew in colonies of the negative violet type on crystal violet agar. In this group, 47% of the isolates coagulated both human and bovine plasmas and were characterized as intermediate type, whereas 24% coagulated human plasma and were classified as human biotype A. Among the fibrinolysin-negative isolates, 15, 12, and 2% were identifiable as animal biotypes B, C, and E, respectively. The cow isolates were classified as intermediate type (51%), human biotype A (40%), and animal biotype C (9%).

Entities:  

Mesh:

Year:  1977        PMID: 931374      PMCID: PMC242683          DOI: 10.1128/aem.34.5.461-464.1977

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  12 in total

1.  OBSERVATIONS ON THE ALIMENTARY TRACT AND ITS BACTERIAL FLORA IN HEALTHY AND DISEASED PIGS.

Authors:  H W SMITH; J E JONES
Journal:  J Pathol Bacteriol       Date:  1963-10

2.  Correlation between staphylococcal phage groups and some staphylococcal enzymes demonstrated by simple methods.

Authors:  T M VOGELSANG; A WORMNES; B OSTERVOLD
Journal:  Acta Pathol Microbiol Scand       Date:  1962

3.  The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram negative bacteria.

Authors:  R HUGH; E LEIFSON
Journal:  J Bacteriol       Date:  1953-07       Impact factor: 3.490

4.  The basis for the present classification of staphylococci and micrococci.

Authors:  A C Baird-Parker
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

5.  Differentiation of Staphylococcus aureus of human and of canine origins: coagulation of human and of canine plasma, fibrinolysin activity, and serologic reaction.

Authors:  I Live
Journal:  Am J Vet Res       Date:  1972-02       Impact factor: 1.156

6.  [On the usability of the crystal-violet test in the differentiation of Staphylococcus aureus strains].

Authors:  W Meyer
Journal:  Z Med Mikrobiol Immunol       Date:  1967

7.  A study of staphylococci isolated from upper respiratory tract of different animal species. 3. Physiological properties of Staphylococcus aureus strains of porcine origin.

Authors:  V Hájek; E Marsálek
Journal:  Zentralbl Bakteriol Orig       Date:  1970

8.  [The differentiation of pathogenic staphylococci and a suggestion for their taxonomic classification].

Authors:  V Hájek; E Marsálek
Journal:  Zentralbl Bakteriol Orig A       Date:  1971-06

9.  TYPES OF HEMOLYSINS PRODUCED BY STAPHYLOCOCCUS AUREUS, AS DETERMINED BY THE REPLICA PLATING TECHNIQUE.

Authors:  R U HAQUE; J N BALDWIN
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

10.  Staphylococci from the feces of different animal species: biotypes of Staphylococcus aureus strains of sheep and goat origin.

Authors:  G Dimitracopoulos; C Sakellariou; J Papavassiliou
Journal:  Appl Environ Microbiol       Date:  1976-07       Impact factor: 4.792

View more
  3 in total

1.  A study into the mechanism of the Crystal Violet reaction in Staphylococcus aureus.

Authors:  M R Barer; D Burdess; R Freeman
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

2.  Comparative host specificity of human- and pig- associated Staphylococcus aureus clonal lineages.

Authors:  Arshnee Moodley; Carmen Espinosa-Gongora; Søren S Nielsen; Alex J McCarthy; Jodi A Lindsay; Luca Guardabassi
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

3.  Phenotypes and genotypes of old and contemporary porcine strains indicate a temporal change in the S. aureus population structure in pigs.

Authors:  Carmen Espinosa-Gongora; Arshnee Moodley; Urszula Lipinska; Els M Broens; Katleen Hermans; Patrick Butaye; Luc A Devriese; Freddy Haesebrouck; Luca Guardabassi
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.